MACLEODS PHARMA USA, INC 2026-04-01 Health serious FDA
Health · FDA · Recall #FDA-D-0403-2026
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for:… Recall
Issued April 1, 2026 · MACLEODS PHARMA USA, INC
In April 2026, MACLEODS PHARMA USA, INC recalled the Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for:…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Subpotent Drug
What you should do
- 1 Stop using Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact MACLEODS PHARMA USA, INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- MACLEODS PHARMA USA, INC
- Category
- Health
- Recall date
- April 1, 2026
- Units affected
- Not reported
- Sold at
- Nationwide
- Recall number
- FDA-D-0403-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- MACLEODS PHARMA USA, INC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.